News

Pivotal Therapeutics Inc. announces the opening of its U.S. headquarters at the Research Park at Florida Atlantic University. The U.S. location will focus upon the commercialization and product distribution of its lead cardiovascular product VASCAZE(TM). (Read more)

Industry

Life Sciences